PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33045572-9	2020	Diosmetin inhibited the production of nitric oxide and decreased the expression of inducible nitric oxide synthase (iNOS).	diosmetin	0-9	nitric oxide synthase 2, inducible	Mus musculus	83-114	
33045572-9	2020	Diosmetin inhibited the production of nitric oxide and decreased the expression of inducible nitric oxide synthase (iNOS).	diosmetin	0-9	nitric oxide synthase 2, inducible	Mus musculus	116-120	
30278036-0	2018	Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-kappaB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.	diosmetin	0-9	nitric oxide synthase 2, inducible	Mus musculus	132-163	
30278036-0	2018	Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-kappaB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.	diosmetin	0-9	nitric oxide synthase 2, inducible	Mus musculus	165-169	
30278036-9	2018	Expression of Akt and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) was significantly reduced and inducible nitric oxide synthase (iNOS) was enhanced in the tissue homogenate of diosmetin-treated mice compared to the negative control group.	diosmetin	207-216	nitric oxide synthase 2, inducible	Mus musculus	127-158	
30278036-9	2018	Expression of Akt and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) was significantly reduced and inducible nitric oxide synthase (iNOS) was enhanced in the tissue homogenate of diosmetin-treated mice compared to the negative control group.	diosmetin	207-216	nitric oxide synthase 2, inducible	Mus musculus	160-164	
30278036-11	2018	CONCLUSIONS Our study shows that diosmetin protects against renal injury in STZ-induced diabetic nephropathy mice by modulating the Akt/NF-kappaB/iNOS signaling pathway.	diosmetin	33-42	nitric oxide synthase 2, inducible	Mus musculus	146-150	
24966921-6	2014	Pretreatment with diosmetin significantly reduced serum levels of amylase and lipase; the histological injury; the secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6; myeloperoxidase (MPO) activity, trypsinogen activation peptide (TAP) level, the expression of inducible nitric oxide synthase (iNOS); and the nuclear factor (NF)-kappaB activation in cerulein-induced AP.	diosmetin	18-27	nitric oxide synthase 2, inducible	Mus musculus	291-322	
24966921-6	2014	Pretreatment with diosmetin significantly reduced serum levels of amylase and lipase; the histological injury; the secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6; myeloperoxidase (MPO) activity, trypsinogen activation peptide (TAP) level, the expression of inducible nitric oxide synthase (iNOS); and the nuclear factor (NF)-kappaB activation in cerulein-induced AP.	diosmetin	18-27	nitric oxide synthase 2, inducible	Mus musculus	324-328